Mark Sims

Vice President - Head of Oncology Business Unit, CANADA at AstraZeneca

Mark Sims is a seasoned executive in the biopharmaceutical industry, currently serving as the Vice President - Head of Oncology Business Unit for AstraZeneca in Canada. His extensive career spans over 20 years, focusing on leadership, strategy development, operational marketing, medical affairs, and sales execution, particularly in oncology.

Professional Background

Current Role: Vice President - Global Franchise Head for Lung Cancer at AstraZeneca since June 2024. Previously served as the Head of Oncology in Canada from April 2021 to May 2023.
Previous Experience:
- Global Commercial Head for Lung Cancer at AstraZeneca (May 2023 - May 2024).
- Held various leadership positions at Novartis, including Vice President and Global Disease Lead for Breast Cancer and Business Franchise Head for Hematology.
Education:
- Bachelor of Commerce (BCom) from McMaster University (1989-1993).
- Additional studies at the Thunderbird School of Global Management (1996-1997).

Leadership Philosophy

Mark is driven by a commitment to innovation in healthcare that enhances patient care standards. His work aims to implement practice changes that significantly benefit cancer patients.

Locations

He has worked primarily out of Gaithersburg, Maryland, and Mississauga, Ontario, Canada.

Mark Sims' LinkedIn profile can be found under the username mark-sims-932b134, where he shares insights and updates related to his professional journey and the oncology sector.